BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:58 PM
 | 
Apr 25, 2007
 |  BC Extra  |  Top Story

XenoPort jumps on RLS data

XNPT gained $12.70 (44%) to $41.56 on 5.6 million shares on Wednesday after XP13512 met the co-primary endpoints in a U.S. Phase III trial to treat moderate to severe restless legs syndrome. In...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >